Precipitating anti-dsDNA peptide repertoires in lupus
- 7 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 194 (3) , 273-282
Abstract
Summary: Anti-double-stranded (ds)DNA autoantibodies are prototypical serological markers of systemic lupus erythematosus (SLE), but little is known about their immunoglobulin variable (IgV) region composition at the level of the secreted (serum) proteome. Here, we use a novel proteomic workflow based on de novo mass spectrometric sequencing of anti-dsDNA precipitins to analyse IgV subfamily expression and mutational signatures of high-affinity, precipitating anti-dsDNA responses. Serum anti-dsDNA proteomes were oligoclonal with shared (public) expression of immunoglobulin (Ig)G heavy chain variable region (IGHV) and kappa chain variable region (IGKV) subfamilies. IgV peptide maps from eight subjects showed extensive public and random (private) amino acid replacement mutations with prominent arginine substitutions across heavy (H)- and light (L)-chains. Shared sets of L-chain complementarity determining region 3 (CDR3) peptides specified by arginine substitutions were sequenced from the dominantly expressed IGKV3-20 subfamily, with changes in expression levels of a clonal L-chain CDR3 peptide by quantitative multiple reaction monitoring (MRM) paralleling the rise and fall of anti-dsDNA levels by Farr radioimmunoassays (RIA). The heavily mutated IgV peptide signatures of precipitating anti-dsDNA autoantibody proteomes reflect the strong selective forces that shape humoral anti-dsDNA responses in germinal centres. Direct sequencing of agarose gel precipitins using microlitre volumes of stored sera streamlines the antibody sequencing workflow and is generalizable to other precipitating serum antibodies.Keywords
Funding Information
- Australian National Health and Medical Research Council (1041900, 1090759)
This publication has 47 references indexed in Scilit:
- Molecular Profiling and Clonal Tracking of Secreted Rheumatoid Factors in Primary Sjögren's SyndromeArthritis & Rheumatology, 2018
- New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti‐DNAArthritis & Rheumatology, 2017
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- Molecular signature of a public clonotypic autoantibody in primary Sjögren's syndrome: A “forbidden” clone in systemic autoimmunityArthritis & Rheumatism, 2011
- Relationship between anti–double‐stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosusArthritis & Rheumatism, 2005
- Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNAMolecular Immunology, 1996
- Analysis of immunoglobulin variable region genes from human IgG anti‐DNA hybridomasEuropean Journal of Immunology, 1992
- Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosusJournal of Autoimmunity, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Detection of anti-DNA antibodies by counterimmunoelectrophoresisJournal of Immunological Methods, 1974